Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (591-600 of 1,211) with videos related to

Pageof 122
Sort By:
European Journal of Heart Failure|January 19, 2013
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)John J V McMurray, Inder S Anand, Rafael Diaz, et al.
JACC. Heart Failure|September 8, 2014
Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (Atherosclerosis Risk In Communities)Deepak K Gupta, Hicham Skali, Brian Claggett, et al.
Cardiovascular Diabetology|June 18, 2022
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trialsMagnus O Wijkman, Brian Claggett, Muthiah Vaduganathan, et al.
Circulation. Heart Failure|March 16, 2019
N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation StatusSøren L Kristensen, Ulrik M Mogensen, Pardeep S Jhund, et al.
The New England Journal of Medicine|November 6, 2012
Cardiorenal end points in a trial of aliskiren for type 2 diabetesHans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
European Journal of Neurology|November 21, 2024
Association of left atrial function with vascular brain injury: The Atherosclerosis Risk in Communities studyWendy Wang, Pamela L Lutsey, Riccardo M Inciardi, et al.
JACC. Heart Failure|July 5, 2023
Prevalent and Incident Anemia in PARADIGM-HF and the Effect of Sacubitril/ValsartanJames P Curtain, Carly Adamson, Kieran F Docherty, et al.
Journal of Hypertension|July 30, 2011
The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertensionAmil M Shah, Carolyn S P Lam, Susan Cheng, et al.
Journal of the American Heart Association|February 8, 2022
Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort StudyDaniel Modin, Brian Claggett, Mads Emil Jørgensen, et al.
Circulation. Heart Failure|October 26, 2018
IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart FailureJames L Januzzi, Milton Packer, Brian Claggett, et al.
Pageof 122

Showing results (591-600 of 1,211) with videos related to

Sort By:
Pageof 122
European Journal of Heart Failure|January 19, 2013
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)John J V McMurray, Inder S Anand, Rafael Diaz, et al.
JACC. Heart Failure|September 8, 2014
Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (Atherosclerosis Risk In Communities)Deepak K Gupta, Hicham Skali, Brian Claggett, et al.
Cardiovascular Diabetology|June 18, 2022
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trialsMagnus O Wijkman, Brian Claggett, Muthiah Vaduganathan, et al.
Circulation. Heart Failure|March 16, 2019
N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation StatusSøren L Kristensen, Ulrik M Mogensen, Pardeep S Jhund, et al.
The New England Journal of Medicine|November 6, 2012
Cardiorenal end points in a trial of aliskiren for type 2 diabetesHans-Henrik Parving, Barry M Brenner, John J V McMurray, et al.
European Journal of Neurology|November 21, 2024
Association of left atrial function with vascular brain injury: The Atherosclerosis Risk in Communities studyWendy Wang, Pamela L Lutsey, Riccardo M Inciardi, et al.
JACC. Heart Failure|July 5, 2023
Prevalent and Incident Anemia in PARADIGM-HF and the Effect of Sacubitril/ValsartanJames P Curtain, Carly Adamson, Kieran F Docherty, et al.
Journal of Hypertension|July 30, 2011
The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertensionAmil M Shah, Carolyn S P Lam, Susan Cheng, et al.
Journal of the American Heart Association|February 8, 2022
Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort StudyDaniel Modin, Brian Claggett, Mads Emil Jørgensen, et al.
Circulation. Heart Failure|October 26, 2018
IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart FailureJames L Januzzi, Milton Packer, Brian Claggett, et al.
Pageof 122